McCombe, P., & D. Henderson, R. (2011). The Role of Immune and Inflammatory Mechanisms in ALS. Current Molecular Medicine. https://doi.org/10.2174/156652411795243450
Adiutori, R., Aarum, J., Zubiri, I., Bremang, M., Jung, S., Sheer, D., … Malaspina, A. (2018). The proteome of neurofilament-containing protein aggregates in blood. Biochemistry and Biophysics Reports, 14, 168–177. https://doi.org/10.1016/j.bbrep.2018.04.010
Amor, S., Peferoen, L. A. N., Vogel, D. Y. S., Breur, M., van der Valk, P., Baker, D., & Van Noort, J. M. (2014). Inflammation in neurodegenerative diseases - an update. Immunology. https://doi.org/10.1111/imm.12233
Ancsin, J. B. (2003). Amyloidogenesis: Historical and modern observations point to heparan sulfate proteoglycans as a major culprit. Amyloid, 10(2), 67–79. https://doi.org/10.3109/13506120309041728
Blasco, H., Veyrat-Durebex, C., Bocca, C., Patin, F., Vourc’H, P., Kouassi Nzoughet, J., … Reynier, P. (2017). Lipidomics Reveals Cerebrospinal-Fluid Signatures of ALS. Scientific Reports. https://doi.org/10.1038/s41598-017-17389-9
Bradley, E. (2012). Incorporating biomarkers into clinical trial designs: points to consider. Nat Biotechnol, 30(7), 596–599. https://doi.org/10.1038/nbt.2296
Cipolat Mis, M. S., Brajkovic, S., Frattini, E., Di Fonzo, A., & Corti, S. (2016). Autophagy in motor neuron disease: Key pathogenetic mechanisms and therapeutic targets. Molecular and Cellular Neuroscience, 72, 84–90. https://doi.org/10.1016/J.MCN.2016.01.012
Conboy, I. M., Conboy, M. J., Wagers, A. J., Girma, E. R., Weismann, I. L., & Rando, T. A. (2005). Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature. https://doi.org/10.1038/nature03260
Delaye, J. B., Patin, F., Piver, E., Bruno, C., Vasse, M., Vourc’h, P., … Blasco, H. (2017). Low IDL-B and high LDL-1 subfraction levels in serum of ALS patients. Journal of the Neurological Sciences. https://doi.org/10.1016/j.jns.2017.07.019
DeWitt, D. A., Richey, P. L., Praprotnik, D., Silver, J., & Perry, G. (1994). Chondroitin sulfate proteoglycans are a common component of neuronal inclusions and astrocytic reaction in neurodegenerative diseases. Brain Research, 656(1), 205–209. https://doi.org/10.1016/0006-8993(94)91386-2
Finn, T. E., Nunez, A. C., Sunde, M., & Easterbrook-Smith, S. B. (2012). Serum albumin prevents protein aggregation and amyloid formation and retains chaperone-like activity in the presence of physiological ligands. J Biol Chem, 287(25), 21530–21540. https://doi.org/10.1074/jbc.M112.372961
Forostyak, S., Homola, A., Turnovcova, K., Svitil, P., Jendelova, P., & Sykova, E. (2014). Intrathecal delivery of mesenchymal stromal cells protects the structure of altered perineuronal nets in SOD1 rats and amends the course of ALS. Stem Cells. https://doi.org/10.1002/stem.1812
Foyez, T., Takeda-Uchimura, Y., Ishigaki, S., Narentuya, N., Zhang, Z., Sobue, G., … Uchimura, K. (2015). Microglial keratan sulfate epitope elicits in central nervous tissues of transgenic model mice and patients with amyotrophic lateral sclerosis. American Journal of Pathology, 185(11), 3053–3065. https://doi.org/10.1016/j.ajpath.2015.07.016
Friedrich, R. P., Tepper, K., Rönicke, R., Soom, M., Westermann, M., Reymann, K., … Fändrich, M. (2010). Mechanism of amyloid plaque formation suggests an intracellular basis of Abeta pathogenicity. Proceedings of the National Academy of Sciences of the United States of America, 107(5), 1942–1947. https://doi.org/10.1073/pnas.0904532106
Garbuzova-Davis, S., Hernandez-Ontiveros, D. G., Rodrigues, M. C., Haller, E., Frisina-Deyo, A., Mirtyl, S., … Sanberg, P. R. (2012). Impaired blood-brain/spinal cord barrier in ALS patients. Brain Res, 1469, 114–128. https://doi.org/10.1016/j.brainres.2012.05.056
Hirano, K., Ohgomori, T., Kobayashi, K., Tanaka, F., Matsumoto, T., Natori, T., … Kadomatsu, K. (2013). Ablation of Keratan Sulfate Accelerates Early Phase Pathogenesis of ALS. PLoS ONE. https://doi.org/10.1371/journal.pone.0066969
Holmes, B. B., DeVos, S. L., Kfoury, N., Li, M., Jacks, R., Yanamandra, K., … Diamond, M. I. (2013). Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1301440110
Hoyles, L., Snelling, T., Umlai, U.-K., Nicholson, J. K., Carding, S. R., Glen, R. C., & McArthur, S. (2018). Microbiome–host systems interactions: protective effects of propionate upon the blood–brain barrier. Microbiome 2018 6:1, 6(1), 55. https://doi.org/10.1186/s40168-018-0439-y
Lee, S., & Kim, H.-J. (2015). Prion-like Mechanism in Amyotrophic Lateral Sclerosis: are Protein Aggregates the Key? Experimental Neurobiology, 24(1), 1–7. https://doi.org/10.5607/en.2015.24.1.1
Lehallier, B., Gate, D., Schaum, N., Nanasi, T., Lee, S. E., Yousef, H., … Wyss-Coray, T. (2019). Undulating changes in human plasma proteome profiles across the lifespan. Nature Medicine, 25(12), 1843–1850. https://doi.org/10.1038/s41591-019-0673-2
Leoni, E., Bremang, M., Mitra, V., Zubiri, I., Jung, S., Lu, C.-H., … Malaspina, A. (2019). Combined Tissue-Fluid Proteomics to Unravel Phenotypic Variability in Amyotrophic Lateral Sclerosis. Scientific Reports, 9(1). https://doi.org/10.1038/s41598-019-40632-4
Ling, S. C., Polymenidou, M., & Cleveland, D. W. (2013). Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron, 79(3), 416–438. https://doi.org/10.1016/j.neuron.2013.07.033
Lu, C.-H., Petzold, A., Kalmar, B., Dick, J., Malaspina, A., & Greensmith, L. (2012). Plasma Neurofilament Heavy Chain Levels Correlate to Markers of Late Stage Disease Progression and Treatment Response in SOD1(G93A) Mice that Model ALS. PLoS One, 7(7), e40998. https://doi.org/10.1371/journal.pone.0040998
Lu, C. H., Kalmar, B., Malaspina, A., Greensmith, L., & Petzold, A. (2011). A method to solubilise protein aggregates for immunoassay quantification which overcomes the neurofilament “hook” effect. J Neurosci Methods, 195(2), 143–150. https://doi.org/10.1016/j.jneumeth.2010.11.026
Lu, C. H., Macdonald-Wallis, C., Gray, E., Pearce, N., Petzold, A., Norgren, N., … Malaspina, A. (2015). Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis. Neurology, 84(22), 2247–2257. https://doi.org/10.1212/wnl.0000000000001642
Lu, C. H., Petzold, A., Topping, J., Allen, K., Macdonald-Wallis, C., Clarke, J., … Malaspina, A. (2015). Plasma neurofilament heavy chain levels and disease progression in amyotrophic lateral sclerosis: insights from a longitudinal study. J Neurol Neurosurg Psychiatry, 86(5), 565–573. https://doi.org/10.1136/jnnp-2014-307672
Ludolph, A., Drory, V., Hardiman, O., Nakano, I., Ravits, J., Robberecht, W., & Shefner, J. (2015). A revision of the El Escorial criteria - 2015. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, Vol. 16, pp. 291–292. https://doi.org/10.3109/21678421.2015.1049183
Lyon, M. S., Wosiski-Kuhn, M., Gillespie, R., Caress, J., & Milligan, C. (2019). Inflammation, Immunity, and amyotrophic lateral sclerosis: I. Etiology and pathology. Muscle and Nerve. https://doi.org/10.1002/mus.26289
McKinley, M. P., Bolton, D. C., & Prusiner, S. B. (1983). A protease-resistant protein is a structural component of the scrapie prion. Cell, 35(1), 57–62.
Ngo, S. T., & Steyn, F. J. (2015). The interplay between metabolic homeostasis and neurodegeneration: insights into the neurometabolic nature of amyotrophic lateral sclerosis. Cell Regen (Lond), 4(1), 5. https://doi.org/10.1186/s13619-015-0019-6
Niccoli, T., Partridge, L., & Isaacs, A. M. (2017). Ageing as a risk factor for ALS/FTD. Human Molecular Genetics, 26(R2), R105–R113. https://doi.org/10.1093/hmg/ddx247
Nishitsuji, K. (2018). Heparan sulfate S-domains and extracellular sulfatases ( Sulfs ): their possible roles in protein aggregation diseases. Glycoconjugate Journal, 387–396. https://doi.org/10.1007/s10719-018-9833-8
Palamiuc, L., Schlagowski, A., Ngo, S. T., Vernay, A., Dirrig-Grosch, S., Henriques, A., … Rene, F. (2015). A metabolic switch toward lipid use in glycolytic muscle is an early pathologic event in a mouse model of amyotrophic lateral sclerosis. EMBO Mol Med, 7(5), 526–546. https://doi.org/10.15252/emmm.201404433
Perez-Riverol, Y., Csordas, A., Bai, J., Bernal-Llinares, M., Hewapathirana, S., Kundu, D. J., … Vizcaíno, J. A. (2019). The PRIDE database and related tools and resources in 2019: Improving support for quantification data. Nucleic Acids Research. https://doi.org/10.1093/nar/gky1106
Petzold, A., Tisdall, M. M., Girbes, A. R., Martinian, L., Thom, M., Kitchen, N., & Smith, M. (2011). In vivo monitoring of neuronal loss in traumatic brain injury: A microdialysis study. Brain. https://doi.org/10.1093/brain/awq360
Polymenidou, M., & Cleveland, D. W. (2011). The seeds of neurodegeneration: prion-like spreading in ALS. Cell, 147(3), 498–508. https://doi.org/10.1016/j.cell.2011.10.011
Quintana, C., Cowley, J. M., & Marhic, C. (2004). Electron nanodiffraction and high-resolution electron microscopy studies of the structure and composition of physiological and pathological ferritin. Journal of Structural Biology. https://doi.org/10.1016/j.jsb.2004.03.001
Russell, C. L., Mitra, V., Hansson, K., Blennow, K., Gobom, J., Zetterberg, H., … Pike, I. (2016). Comprehensive Quantitative Profiling of Tau and Phosphorylated Tau Peptides in Cerebrospinal Fluid by Mass Spectrometry Provides New Biomarker Candidates. Journal of Alzheimer’s Disease, 55(1), 303–313. https://doi.org/10.3233/JAD-160633
Saez, I., & Vilchez, D. (2014). The Mechanistic Links Between Proteasome Activity, Aging and Age-related Diseases. Curr Genomics, 15(1), 38–51. https://doi.org/10.2174/138920291501140306113344
Safar, J. G., Wille, H., Geschwind, M. D., Deering, C., Latawiec, D., Serban, A., … Prusiner, S. B. (2006). Human prions and plasma lipoproteins. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.0604021103
Sana, B., Poh, C. L., & Lim, S. (2012). A manganese-ferritin nanocomposite as an ultrasensitive T2contrast agent. Chemical Communications. https://doi.org/10.1039/c1cc15189d
Sarrazin, S., Lamanna, W. C., & Esko, J. D. (2011). Heparan sulfate proteoglycans. Cold Spring Harbor Perspectives in Biology, 3(7), 1–33. https://doi.org/10.1101/cshperspect.a004952
Sasaki, S. (2011). Autophagy in spinal cord motor neurons in sporadic amyotrophic lateral sclerosis. J Neuropathol Exp Neurol, 70. https://doi.org/10.1097/NEN.0b013e3182160690
Shi, Y., Lin, S., Staats, K. A., Li, Y., Chang, W. H., Hung, S. T., … Ichida, J. K. (2018). Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons. Nat Med. https://doi.org/10.1038/nm.4490
Shijo, T., Warita, H., Suzuki, N., Kitajima, Y., Ikeda, K., Akiyama, T., … Aoki, M. (2018). Aberrant astrocytic expression of chondroitin sulfate proteoglycan receptors in a rat model of amyotrophic lateral sclerosis. Journal of Neuroscience Research, 96(2), 222–233. https://doi.org/10.1002/jnr.24127
Song, C., Guo, J., Liu, Y., & Tang, B. (2012). Autophagy and Its Comprehensive Impact on ALS. International Journal of Neuroscience, 122(12), 695–703. https://doi.org/10.3109/00207454.2012.714430
Sullivan, P. M., Zhou, X., Robins, A. M., Paushter, D. H., Kim, D., Smolka, M. B., & Hu, F. (2016). The ALS/FTLD associated protein C9orf72 associates with SMCR8 and WDR41 to regulate the autophagy-lysosome pathway. Acta Neuropathologica Communications. https://doi.org/10.1186/s40478-016-0324-5
Supattapone, S. (2012). Phosphatidylethanolamine as a prion cofactor: Potential implications for disease pathogenesis. Prion. https://doi.org/10.4161/pri.21826
Szelechowski, M., Amoedo, N., Obre, E., Léger, C., Allard, L., Bonneu, M., … Rossignol, R. (2018). Metabolic Reprogramming in Amyotrophic Lateral Sclerosis. Scientific Reports. https://doi.org/10.1038/s41598-018-22318-5
Tefera, T. W., & Borges, K. (2017). Metabolic dysfunctions in amyotrophic lateral sclerosis pathogenesis and potential metabolic treatments. Frontiers in Neuroscience. https://doi.org/10.3389/fnins.2016.00611
Terry, C., Wenborn, A., Gros, N., Sells, J., Joiner, S., Hosszu, L. L. P., … Wadsworth, J. D. F. (2016). Ex vivo mammalian prions are formed of paired double helical prion protein fibrils. Open Biology. https://doi.org/10.1098/rsob.160035
Villeda, S. A., Luo, J., Mosher, K. I., Zou, B., Britschgi, M., Bieri, G., … Wyss-Coray, T. (2011). The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature. https://doi.org/10.1038/nature10357
Weids, A. J., Ibstedt, S., Tamas, M. J., & Grant, C. M. (2016). Distinct stress conditions result in aggregation of proteins with similar properties. Sci Rep, 6, 24554. https://doi.org/10.1038/srep24554
Weksler, B. B., Subileau, E. A., Perrière, N., Charneau, P., Holloway, K., Leveque, M., … Couraud, P. O. (2005). Blood-brain barrier-specific properties of a human adult brain endothelial cell line. FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology, 19(13), 1872–1874. https://doi.org/10.1096/fj.04-3458fje
Williams, S. A., Kivimaki, M., Langenberg, C., Hingorani, A. D., Casas, J. P., Bouchard, C., … Wareham, N. J. (2019). Plasma protein patterns as comprehensive indicators of health. Nature Medicine, 25(12), 1851–1857. https://doi.org/10.1038/s41591-019-0665-2
Xia, K., Trasatti, H., Wymer, J. P., & Colon, W. (2016). Increased levels of hyper-stable protein aggregates in plasma of older adults. Age (Dordr), 38(3), 56. https://doi.org/10.1007/s11357-016-9919-9
Yang, H., & Hu, H. Y. (2016). Sequestration of cellular interacting partners by protein aggregates: implication in a loss-of-function pathology. FEBS J, 283(20), 3705–3717. https://doi.org/10.1111/febs.13722
Zhang, B., Kirov, S., & Snoddy, J. (2005). WebGestalt: An integrated system for exploring gene sets in various biological contexts. Nucleic Acids Research, 33(SUPPL. 2), 741–748. https://doi.org/10.1093/nar/gki475
Zhou, Z., Fan, J.-B., Zhu, H.-L., Shewmaker, F., Yan, X., Chen, X., … Liang, Y. (2009). Crowded Cell-like Environment Accelerates the Nucleation Step of Amyloidogenic Protein Misfolding. Journal of Biological Chemistry, 284(44), 30148–30158. https://doi.org/10.1074/jbc.M109.002832
Zubiri, I., Lombardi, V., Bremang, M., Mitra, V., Nardo, G., Adiutori, R., … Malaspina, A. (2018). Tissue-enhanced plasma proteomic analysis for disease stratification in amyotrophic lateral sclerosis. Molecular Neurodegeneration, 13(1), 60. https://doi.org/10.1186/s13024-018-0292-2